Ashrafizadeh, Milad and Mirzaei, Sepideh and Hashemi, Farid and Zarrabi, Ali and Zabolian, Amirhossein and Saleki, Hossein and Sharifzadeh, Seyed Omid and Soleymani, Leyla and Daneshi, Salman and Hushmandi, Kiavash and Khan, Haroon and Kumar, Alan Prem and Aref, Amir Reza and Samarghandian, Saeed (2026) Retraction notice to "New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities"(Biomedicine & Pharmacotherapy, (2021), 141, C, (111824), (S0753332221006065), 10.1016/j.biopha.2021.111824). Biomedicine and Pharmacotherapy, 198 . ISSN 0753-3322 (Print) 1950-6007 (Online)
Full text not available from this repository. (Request a copy)
Official URL: https://dx.doi.org/10.1016/j.biopha.2026.119228
Abstract
This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been retracted at the request of the Editor. Post-publication, an investigation conducted by Elsevier's Research Integrity & Publishing Ethics team on behalf of the journal identified references that are irrelevant to the article. The authors were asked to comment upon the presence of these references in their work but did not respond. Consequently, the editor has lost confidence in the conclusions of the article and has determined it should be retracted. The authors disagree with retraction and dispute the grounds for it.
| Item Type: | Article |
|---|---|
| Additional Information: | Document type: Erratum |
| Divisions: | Faculty of Engineering and Natural Sciences Sabancı University Nanotechnology Research and Application Center |
| Depositing User: | Ali Zarrabi |
| Date Deposited: | 29 Apr 2026 11:08 |
| Last Modified: | 29 Apr 2026 11:08 |
| URI: | https://research.sabanciuniv.edu/id/eprint/53908 |
Actions (login required)
- View Item